NYC Health+Hospitals merges with Maimonides Medical Center

NYC Health+Hospitals is proceeding with a planned $2.2 billion merger with Maimonides Medical Center, though regulatory hurdles have introduced potential delays. The integration is intended to stabilize Maimonides' finances and enhance healthcare access by boosting Medicaid revenues. The acquisition, originally slated for completion on April 1, now hinges on a pending court review prompted by the New York State Attorney General’s decision not to grant immediate administrative approval.

The merger requires oversight from the Attorney General’s Charities Bureau and the state's Department of Health due to Maimonides' nonprofit status. However, a pending lawsuit from some members of the Maimonides Board of Trustees led the AG's office to recommend a judicial review by the Brooklyn Supreme Court. This move necessitates a series of legal evaluations to affirm the fairness and suitability of the transaction terms. Both entities have pledged to follow through expediently with the necessary procedural requirements.

The driving force behind the merger is Maimonides' financial difficulties. The hospital serves as a critical safety net with over 100,000 patients annually, relying heavily on Medicaid and Medicare reimbursements, which accounted for 80% of its patient base last year. The hospital reported a $15 million loss in the first nine months of 2025 while generating only $1.5 million, highlighting the dire need for financial intervention. By merging with NYC Health+Hospitals, a significant influx of resources from the city’s public health network aims to support and extend Maimonides' services, ensuring continuity and expansion of care in Brooklyn.

In the broader healthcare landscape, this merger highlights ongoing challenges for nonprofit hospitals facing financial pressures, primarily those serving low-income or publicly insured populations. The shift could set a precedent for similar institutions seeking support from larger public entities or networks to remain viable. It underscores the growing trend of healthcare system consolidations as a strategic response to sectoral financial stress and operational inefficiencies.

The court's forthcoming decision will be pivotal in determining the merger's future trajectory. Key leadership transitions, such as the planned replacement of Maimonides CEO Ken Gibbs with NYC Health+Hospitals' Svetlana Lipyanskaya, remain contingent upon the merger's legal consummation. Both parties remain optimistic, expressing continued commitment to fulfilling regulatory demands and advancing their shared mission of improving healthcare services for New Yorkers.